Edition:
India

Astrazeneca Pharma India Ltd (ASTR.NS)

ASTR.NS on National Stock Exchange of India

915.75INR
20 Jun 2017
Change (% chg)

Rs-3.50 (-0.38%)
Prev Close
Rs919.25
Open
Rs922.95
Day's High
Rs922.95
Day's Low
Rs915.00
Volume
5,276
Avg. Vol
20,479
52-wk High
Rs1,145.00
52-wk Low
Rs908.00

ASTR.NS

Chart for ASTR.NS

About

AstraZeneca Pharma India Limited is a global biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease. The Company operates through two... (more)
No analyst recommendations are available for ASTR.NS.

Overall

Beta: 0.45
Market Cap(Mil.): Rs22,913.75
Shares Outstanding(Mil.): 25.00
Dividend: --
Yield (%): --

Financials

  ASTR.NS Industry Sector
P/E (TTM): 93.70 13.51 17.41
EPS (TTM): 9.78 -- --
ROI: 13.51 -7.01 -5.24
ROE: 14.53 -6.49 -4.49

BRIEF-Astrazeneca Pharma India gets import and market permission from DCGI for FDC of asthma drug

* Received import and market permission in form 45 from DCGI (Drug Controller General of India)for FDC of Budesonide 320 μg + Formoterol Fumarate Dihydrate 9 μg inhalation powder

15 Jun 2017

Sensex, Nifty hit record closing high

Indian shares closed at a record high on Tuesday, with the NSE Nifty crossing 9,500 points intraday for the first time ever, as expectations of good monsoon rains eased inflation fears and bolstered the economic growth outlook.

16 May 2017

Indian shares hit all-time high in record-setting spree

May 16 Indian shares continued their record-setting spree on Tuesday, hitting all-time highs for the third time in five sessions, as investors remained bullish about the prospects of a good monsoon.

16 May 2017

BRIEF-Astrazeneca Pharma India posts March-qtr loss

* March quarter total income from operations 1.12 billion rupees

09 May 2017

BRIEF-Pfizer enters into delegation of authority with Astrazeneca Pharma India

* Pfizer Ltd says entered into delegation of authority with Astrazeneca Pharma India

18 Jan 2017

More From Around the Web

Earnings vs. Estimates

No consensus analysis data available.